Fin Trust Capital Advisors, LLC Biogen Inc. Transaction History
Fin Trust Capital Advisors, LLC
- $577 Million
- Q3 2024
A detailed history of Fin Trust Capital Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 419 shares of BIIB stock, worth $72,818. This represents 0.01% of its overall portfolio holdings.
Number of Shares
419
Previous 407
2.95%
Holding current value
$72,818
Previous $94,000
13.83%
% of portfolio
0.01%
Previous 0.02%
Shares
16 transactions
Others Institutions Holding BIIB
# of Institutions
1,018Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$2.88 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.84 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.53 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.23 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$987 Million0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $25B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...